Telesis Bio, Inc. (TBIO)
USD 0.49
(-7.55%)
USD 0.49
(-7.55%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -40.49 Million USD | 33.25% |
| 2022 | -43.61 Million USD | -37.35% |
| 2021 | -36 Million USD | -126.08% |
| 2020 | -15.49 Million USD | -144.78% |
| 2019 | -6.11 Million USD | 93.89% |
| 2018 | -100.11 Million USD | -29.45% |
| 2017 | -77.33 Million USD | -197.82% |
| 2016 | -25.96 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -7.34 Million USD | -48.67% |
| 2024 Q2 | -9.66 Million USD | -43.53% |
| 2023 Q3 | -9.24 Million USD | -16.04% |
| 2023 Q2 | -7.96 Million USD | 27.6% |
| 2023 Q4 | -4.94 Million USD | 46.57% |
| 2023 FY | - USD | 33.25% |
| 2023 Q1 | -11 Million USD | -39.47% |
| 2022 FY | - USD | -37.35% |
| 2022 Q1 | -12.28 Million USD | -5.38% |
| 2022 Q4 | -7.89 Million USD | 29.82% |
| 2022 Q3 | -11.24 Million USD | 18.82% |
| 2022 Q2 | -13.85 Million USD | -12.78% |
| 2021 FY | - USD | -126.08% |
| 2021 Q1 | -5.92 Million USD | -23.24% |
| 2021 Q2 | -7.19 Million USD | -21.52% |
| 2021 Q4 | -11.65 Million USD | -28.3% |
| 2021 Q3 | -9.08 Million USD | -26.18% |
| 2020 Q1 | -3.22 Million USD | 88.98% |
| 2020 Q2 | -3 Million USD | 6.89% |
| 2020 Q3 | -3.94 Million USD | -31.41% |
| 2020 Q4 | -4.8 Million USD | -21.85% |
| 2020 FY | - USD | -144.78% |
| 2019 Q4 | -29.25 Million USD | -44.57% |
| 2019 FY | - USD | 93.89% |
| 2019 Q3 | -20.23 Million USD | 24.76% |
| 2019 Q2 | -26.89 Million USD | 17.64% |
| 2019 Q1 | -32.65 Million USD | -487.6% |
| 2018 Q1 | -21.77 Million USD | 9.65% |
| 2018 Q2 | -28.09 Million USD | -29.0% |
| 2018 Q3 | -44.69 Million USD | -59.1% |
| 2018 Q4 | -5.55 Million USD | 87.56% |
| 2018 FY | - USD | -29.45% |
| 2017 FY | - USD | -197.82% |
| 2017 Q1 | -14.61 Million USD | 0.0% |
| 2017 Q2 | -18.25 Million USD | -24.91% |
| 2017 Q3 | -20.37 Million USD | -11.59% |
| 2017 Q4 | -24.1 Million USD | -18.32% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -200.237% |
| Biotricity, Inc. | -8.82 Million USD | -358.674% |
| Cell MedX Corp. | - USD | Infinity% |
| Dynatronics Corporation | -976 Thousand USD | -4048.839% |
| Nemaura Medical Inc. | -7.28 Million USD | -455.684% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -285.85% |
| RetinalGenix Technologies Inc. | -2.08 Million USD | -1840.297% |
| Sonendo, Inc. | -54.76 Million USD | 26.064% |
| Talis Biomedical Corporation | -66.04 Million USD | 38.689% |
| Viveve Medical, Inc. | -20.61 Million USD | -96.406% |